| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/23/2006 | EP1693385A1 Humanized anti-cd47 antibody |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693069A1 Remedy for solid tumor |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693066A2 Immortalized human keratinocyte cell line |
| 08/23/2006 | EP1693062A2 Androgen receptor-dependent gene expression control |
| 08/23/2006 | EP1693052A1 Compositions for delivery of drug combinations |
| 08/23/2006 | EP1692305A1 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692184A2 Antibodies that bind interleukin-4 receptor |
| 08/23/2006 | EP1692183A2 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 08/23/2006 | EP1692141A1 Substituted 3-amino-thieno¬2,3-b| pyridine-2-carboxylic acid amide compounds as ikk inhibitors |
| 08/23/2006 | EP1692140A1 Compositions useful as inhibitors of protein kinases |
| 08/23/2006 | EP1692125A2 Irciniastatins a and b |
| 08/23/2006 | EP1692123A1 Phenyl-furan compounds as vitamin d receptor modulators |
| 08/23/2006 | EP1692099A1 Somatostatine receptor subtype 1 (sstr1) active compounds and their use in therapy |
| 08/23/2006 | EP1692097A1 Tricyclic hydroxamate and benzamide derivatives, compositions and methods |
| 08/23/2006 | EP1692085A2 Inhibition of fgfr3 and treatment of multiple myeloma |
| 08/23/2006 | EP1691842A1 Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent |
| 08/23/2006 | EP1691838A2 Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs |
| 08/23/2006 | EP1691836A2 Anti-pecam therapy for metastasis suppression |
| 08/23/2006 | EP1691824A2 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 08/23/2006 | EP1691816A2 Pharmaceutical uses of bisphosphonates |
| 08/23/2006 | EP1691809A1 Combination therapy comprising the use of et-743 and paclitaxel for treating cancer |
| 08/23/2006 | EP1691805A1 The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 08/23/2006 | EP1691801A2 Synergistic anti-cancer compositions |
| 08/23/2006 | EP1691664A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| 08/23/2006 | EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 08/23/2006 | EP1583524B1 Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
| 08/23/2006 | EP1534271B1 Antitumor compound and therapeutic uses thereof |
| 08/23/2006 | EP1515740B1 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 08/23/2006 | EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 08/23/2006 | EP1476426B1 Hydroxylated indirubin derivatives |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1363920B1 Modified psma ligands and uses related thereto |
| 08/23/2006 | EP1358318B1 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/23/2006 | EP1345907B1 7-heterocyclyl quinoline and thieno 2,3-b|pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/23/2006 | EP1272457B1 Compounds for modulating cell proliferation |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1198232B1 Urea substituted imidazoquinolines |
| 08/23/2006 | EP1189637B1 Compositions for improving bioavailability of orally administered drugs |
| 08/23/2006 | EP1165570B1 Novel phosphorus-containing prodrugs |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
| 08/23/2006 | EP1051482B1 Cytotoxic heteromeric protein combinatorial libraries |
| 08/23/2006 | EP0833636B1 Method for inhibiting neoplastic disease in mammals |
| 08/23/2006 | EP0822831B2 Vaccines containing a saponin and a sterol |
| 08/23/2006 | CN1823076A Silicon compounds and their use |
| 08/23/2006 | CN1823067A Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 08/23/2006 | CN1823066A Substituted tetrahydro-1h-pyrazolo [3,4-c]pyridines, compositions comprising them, and use |
| 08/23/2006 | CN1823039A Cyclic aminophenyl sulfamate derivative |
| 08/23/2006 | CN1822847A Plant worms mycelium extracat fraction and composition for oral intake |
| 08/23/2006 | CN1822844A Glycoside-containing liposome |
| 08/23/2006 | CN1821410A Recombinant adenovirus containing codon optimized type IIPV16L1 gene |
| 08/23/2006 | CN1821403A Gene up regulation expressed by hepatitis B virus X antigen and its coded product and use |
| 08/23/2006 | CN1821275A Ginseng extracting method for separating ginseng polyose and extract and use of ginseng polyose |
| 08/23/2006 | CN1821268A Goniothalamicim cyclopeptide B of anti-tumor compound and isomer and its preparing method |
| 08/23/2006 | CN1821262A Lonicera macranthoides active total saponin extract and its preparing method and use |
| 08/23/2006 | CN1821254A Artificially cultivating nucleoside active matter in cordycepin and its preparing method and use |
| 08/23/2006 | CN1821253A Novel water soluble Pt (II) anti-cancer ligand and its preparing method |
| 08/23/2006 | CN1821247A Camptothecine derivatives and their use |
| 08/23/2006 | CN1821202A Active compound bulbophyllum phenanthrene dimer A and its use |
| 08/23/2006 | CN1821201A Active compound bulbophyllum phenanthrene dimer B and its use |
| 08/23/2006 | CN1820785A Anti-tumor medicine |
| 08/23/2006 | CN1820781A Use of compound PS-341 in preparing medicine for treating chronic granulocytic leukemia |
| 08/23/2006 | CN1820764A Process for preparing micrometer Huishusanhua lucid ganoderma spore anti-tumour matation oral liquor |
| 08/23/2006 | CN1820763A Process for preparing micrometer Huishusanhua lucid ganoderma spore anti-tumour mutation granule, capsule and tablet |
| 08/23/2006 | CN1820753A Freeze-dried powder injection containing leucovorin sodium and its preparing method |
| 08/23/2006 | CN1820734A Treatment with anti-erbb2 antibodies |
| 08/23/2006 | CN1820616A Biological health tea |
| 08/23/2006 | CN1271205C Reconstituted human anti-HM1.24 antibody |
| 08/23/2006 | CN1271083C Composition, extraction process and use of total triterpene sapogenin extracted from bamboo |
| 08/23/2006 | CN1271082C Sulfonated sterol, preparing method and application |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1270775C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/23/2006 | CN1270769C Cinobufotalin lyophilized powder for injection and its preparation method |
| 08/23/2006 | CN1270753C Compound formule chinaroot greenbrier capsule and its preparation method |
| 08/23/2006 | CN1270716C Freezing-drying powder-injection contg. sodium folinate, and its prepn. method |
| 08/23/2006 | CN1270699C 'Shengmai' injection and its preparation process |
| 08/23/2006 | CN1270643C 'Wuzhi' health-care beverage |
| 08/22/2006 | US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 08/22/2006 | US7094903 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/22/2006 | US7094896 Diaminothiazoles having antiproliferative activity |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094876 Human cDNAs and proteins and uses thereof |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094797 Organ fibrosis inhibitor |
| 08/22/2006 | US7094785 administering Imatinib or a salt, especially the mesylate; reduced the need for a phlebotomy. |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094774 26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 08/22/2006 | US7094755 Therapy and prophylaxis of cancer |
| 08/22/2006 | US7094557 Antitumor agents; controlling cell proliferation |
| 08/22/2006 | US7094556 Diagnosis and treatment of malignant neoplasms |